Comparar métodos
Examine os métodos selecionados lado a lado; as linhas que diferem ficam destacadas.
| Análise de Séries Temporais Interrompidas (ITS)× | Propensity Score Matching× | |
|---|---|---|
| Área≠ | Inferência causal | Estatística para pesquisa |
| Família≠ | Regression model | Process / pipeline |
| Ano de origem≠ | 2002 | 1983 |
| Autor original≠ | Wagner, Soumerai, Zhang & Ross-Degnan (segmented regression); Bernal, Cummins & Gasparrini (tutorial) | Paul Rosenbaum and Donald Rubin |
| Tipo≠ | Quasi-experimental segmented regression | Method |
| Fonte seminal≠ | Bernal, J. L., Cummins, S., & Gasparrini, A. (2017). Interrupted time series regression for the evaluation of public health interventions: a tutorial. International Journal of Epidemiology, 46(1), 348-355. DOI ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Outros nomes | ITS analysis, segmented regression of time series, Kesintili Zaman Serisi (ITS) Analizi | PSM, propensity score weighting, covariate balance |
| Relacionados≠ | 5 | 3 |
| Resumo≠ | Interrupted Time Series analysis is a quasi-experimental design that estimates the effect of a single, well-dated intervention by comparing the trajectory of an outcome before and after it occurs. Formalised as segmented regression by Wagner and colleagues (2002) and popularised as a public-health evaluation tutorial by Bernal, Cummins and Gasparrini (2017), it separates the intervention's impact into a change in level and a change in slope. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateConjunto de dados ↗ |
|
|